Healthcare employees transfer a affected person within the Covid-19 Unit at United Memorial Medical Middle in Houston, Texas Thursday, July 2, 2020.Mark Felix | Getty ImagesThe unfold of the coronavirus could possibly be elevated this fall with as many as 150,000 every day circumstances within the U.S., in line with Morgan Stanley’s biotechnology analyst, Matthew Harrison.”We replace our situations to account for the upper sustained an infection price,” Harrison stated in a word Thursday. “Our bull [most optimistic] case displays related virus management to Europe whereas our base [most likely] case assumes a near-term plateau adopted by elevated unfold within the fall. [About] 150,000 every day new circumstances are potential with out higher management of the virus.”Harrison beforehand projected a “second wave” within the autumn with every day new circumstances totaling between 40,000 and 50,000 nationwide. Nonetheless, the current emergence of scorching spots — Arizona, Texas, Florida and California — has mirrored a excessive price of an infection, which led the analyst to regulate to a extra pessimistic view on the pandemic.The analyst has gained a large following on Wall Street for his success in predicting the course of the pandemic and authorities responses. For instance, in April, Harrison warned that the reopening of the U.S. economic system can be a gradual and tedious course of.”Our assumption of a rising replica quantity, and consequently rising every day circumstances, all through the remainder of the yr relies on the truth that historically the unfold of viruses is elevated within the fall in comparison with the summer season primarily resulting from extra individuals in enclosed areas,” Harrison stated.A current resurgence in new circumstances has compelled various states to roll again their reopening plans, which weighed on the stock market that rallied massively within the second quarter on hopes for a quick financial restoration. Texas and Florida hit grim data earlier this week for every day coronavirus deaths based mostly on a seven-day shifting common.The virus has contaminated a mean of 66,805 individuals per day within the U.S. over the previous seven days, up greater than 7% in contrast with every week in the past, in line with a CNBC evaluation of knowledge compiled by Johns Hopkins College. On Wednesday, California Gov. Gavin Newsom reported a report spike in every day infections, surpassing New York because the U.S. state with probably the most confirmed infections because the pandemic started.To make sure, Harrison stated his projection does not consider any pharmacological intervention resembling vaccines or strict lockdown measures that might probably dampen the an infection price.There was a slew of constructive information on the vaccine entrance this week. The U.S. agreed to pay drugmaker Pfizer and German companion BioNTech practically $2 billion for 100 million coronavirus vaccine doses if their candidate proves each protected and efficient.In the meantime, one other vaccine candidate from Oxford College and AstraZeneca confirmed a constructive immune response in an early trial. Earlier this week, British pharmaceutical firm Synairgen claimed that its new respiratory coronavirus therapy has diminished the variety of hospitalized Covid-19 sufferers needing intensive care in a scientific trial.Goldman Sachs biotech analyst Salveen Richter stated the Covid-19 vaccine market can be much like the flu vaccine market, which requires an annual or periodic vaccination. The analyst additionally cited knowledge displaying the international vaccine market will develop to no less than $40 billion in 2023 from $35 billion in 2018.— CNBC’s Michael Bloom contributed reporting.Subscribe to CNBC PRO for unique insights and evaluation, and stay enterprise day programming from world wide.